LOCALLY ADVANCED LARYNGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for LOCALLY ADVANCED LARYNGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED LARYNGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED LARYNGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to boost radiation for head and neck cancer
Disease control Recruiting nowThis early-phase trial is testing whether adding the experimental drug ipatasertib to standard chemotherapy and radiation can better control advanced head and neck cancer. About 46 adults with certain types of head and neck cancer will receive the combination to find the safest d…
Matched conditions: LOCALLY ADVANCED LARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 04:33 UTC
-
New drug combo aims to spare voice box in advanced throat cancer
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug toripalimab to standard chemotherapy can help control advanced laryngeal or hypopharyngeal cancer while avoiding removal of the voice box (laryngectomy). About 87 adults with stage III-IV disease that is surgically removable …
Matched conditions: LOCALLY ADVANCED LARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Matthew Spector • Aim: Disease control
Last updated May 14, 2026 12:03 UTC